Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports

by Meissner, Magdalena, Addeo, Alfredo
Published in Case Rep Oncol (2016)

First-line alectinib for ALK-positive lung cancer: is there room for further improvement?

by Addeo, Alfredo, Metro, Giulio
Published in Drugs Context (2018)

Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient

by Addeo, Alfredo, Rinaldi, Ciro Roberto
Published 2013

The crucial role of predicting brain metastases development in non-small cell lung cancer patients

by Addeo, Alfredo, Banna, Giuseppe Luigi
Published in J Thorac Dis (2018)

PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

by Addeo, Alfredo, Banna, Giuseppe Luigi
Published in Transl Lung Cancer Res (2018)

PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

by Addeo, Alfredo, Banna, Giuseppe Luigi
Published in Transl Lung Cancer Res (2018)

Measuring tumor mutation burden in cell-free DNA: advantages and limits

by Addeo, Alfredo, Weiss, Glen J.
Published in Transl Lung Cancer Res (2019)

New emerging targets in cancer immunotherapy: the role of TIM3

by Friedlaender, Alex, Addeo, Alfredo, Banna, Giuseppe
Published in ESMO Open (2019)

Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic

by Friedlaender, Alex, Kim, Chul, Addeo, Alfredo
Published in Front Oncol (2020)

COVID-19 and lung cancer: risks, mechanisms and treatment interactions

by Addeo, Alfredo, Obeid, Michel, Friedlaender, Alex
Published in J Immunother Cancer (2020)

Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis

by Addeo, Alfredo, Weiss, Glen J., Gyawali, Bishal
Published in JAMA Netw Open (2019)

Tracking the tail

by Friedlaender, Alex, Liu, Stephen V, Addeo, Alfredo
Published in J Immunother Cancer (2020)

ADAURA: Mature Enough for Publication, Not for Prime Time

by Addeo, Alfredo, Banna, Giuseppe Luigi, Friedlaender, Alex
Published in Oncologist (2020)

KRAS G12C Mutations in NSCLC: From Target to Resistance

by Addeo, Alfredo, Banna, Giuseppe Luigi, Friedlaender, Alex
Published in Cancers (Basel) (2021)

Learning from the past to design better trials in second-line treatment for mesothelioma patients

by Addeo, Alfredo, Banna, Giuseppe Luigi, Dietrich, Pierre-Yves
Published in Ecancermedicalscience (2018)

The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre Experience

by TORRALVO, JAVIER, FRIEDLAENDER, ALEX, ACHARD, VERANE, ADDEO, ALFREDO
Published in Cancer Genomics Proteomics (2019)

Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer

by CHEVALLIER, MATHIEU, TSANTOULIS, PETROS, ADDEO, ALFREDO, FRIEDLAENDER, ALEX
Published in Cancer Genomics Proteomics (2020)

Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer

by Mederos, Nuria, Friedlaender, Alex, Peters, Solange, Addeo, Alfredo
Published in ESMO Open (2020)

Oncogenic driver mutations in non-small cell lung cancer: Past, present and future

by Chevallier, Mathieu, Borgeaud, Maxime, Addeo, Alfredo, Friedlaender, Alex
Published in World J Clin Oncol (2021)

Identifying successful biomarkers for patients with non-small-cell lung cancer

by Friedlaender, Alex, Bauml, Joshua, Banna, Giuseppe Luigi, Addeo, Alfredo
Published in Lung Cancer Manag (2019)